Skip to main content

Advertisement

SpringerLink
Log in

CARD15 mutations and colorectal cancer in a South European country

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Purpose

CARD15 mutations are associated with higher susceptibility to Crohn's disease (CD) and longstanding colonic CD increases the risk of developing colorectal cancer (CRC). The relation between these mutations and sporadic CRC remains controversial. The aim of this study was to assess whether germline and/or somatic CARD15 mutations are risk factors for sporadic CRC in Portugal and whether there are genotype–phenotype correlations in these patients.

Methods

The three main CARD15 mutations (R702W, G908R and 3020insC) were researched in 112 sporadic CRC patients and 152 healthy subjects.

Results

Overall, CARD15 mutations were found in 18 patients (16.1%) and in 15 controls (9.9%; p = 0.132). Individually, the incidence of R702W was significantly higher in patients than in controls (12.5% vs. 5.3%, p = 0.035), whereas the genotype frequencies for G908R (2.7% vs. 3.3%) and 3020insC (0.9% vs. 1.3%) were not statistically different between the two groups. Entire genotypic agreement was found in patients genotyped for blood and neoplastic DNA. A significantly higher incidence of CARD15 mutations was detected in patients with CRC diagnosed under 60 years old (28.6% vs. 10.4%, p = 0.015) and in female patients (24.4% vs. 10.4%, p = 0.048). No associations were found between CARD15 mutations and family history, symptoms or CRC pathologic characteristics.

Conclusions

The CARD15 R702W variant might be a predisposing factor to sporadic CRC in Portugal, particularly in patients under 60-years old and in female patients. This susceptibility appears to be linked with germline CARD15 mutations. Nevertheless, we have found no evidence that CARD15 mutations predict the pathologic characteristics of CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Boyle P, Langman JS (2000) ABC of colorectal cancer: epidemiology. BMJ 321:805–808

    Article  CAS  PubMed  Google Scholar 

  2. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543

    Article  CAS  PubMed  Google Scholar 

  3. Ferlay J, Autier P, Boniol M et al (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581–592

    Article  CAS  PubMed  Google Scholar 

  4. Tejpar S, Van Cutsem E (2002) Molecular and genetic defects in colorectal tumorigenesis. Best Pract Res Clin Gastroenterol 16:171–185

    Article  CAS  PubMed  Google Scholar 

  5. Lakatos PL, Lakatos L (2006) Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome. Orv Hetil 147:449–455

    PubMed  Google Scholar 

  6. Popat S, Wort R, Houlston RS (2006) Inter-relationship between microsatellite instability, thymidylate synthase expression, and p53 status in colorectal cancer: implications for chemoresistance. BMC Cancer 6:150

    Article  PubMed  Google Scholar 

  7. Fuszek P, Lakatos P, Tabak A et al (2004) Relationship between serum calcium and CA 19-9 levels in colorectal cancer. World J Gastroenterol 10:1890–1892

    CAS  PubMed  Google Scholar 

  8. Rhodes JM, Campbell BJ (2002) Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med 8:10–16

    Article  CAS  PubMed  Google Scholar 

  9. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860–867

    Article  CAS  PubMed  Google Scholar 

  10. Williams MP, Pounder RE (1999) Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol 94:S11–S16

    Article  CAS  PubMed  Google Scholar 

  11. Munkholm P (2003) Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 18:1–5

    Article  PubMed  Google Scholar 

  12. Higaki S, Akazawa A, Nakamura H et al (1999) Metaplastic polyp of the colon develops in response to inflammation. J Gastroenterol Hepatol 14:709–714

    Article  CAS  PubMed  Google Scholar 

  13. Eberhart CE, Coffey RJ, Radhika A et al (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183–1188

    CAS  PubMed  Google Scholar 

  14. Phoa N, Epe B (2002) Influence of nitric oxide on the generation and repair of oxidative DNA damage in mammalian cells. Carcinogenesis 23:469–475

    Article  CAS  PubMed  Google Scholar 

  15. Jackson AL, Loeb LA (2001) The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 477:7–21

    CAS  PubMed  Google Scholar 

  16. Moore MA (2002) Cytokine and chemokine networks influencing stem cell proliferation, differentiation, and marrow homing. J Cell Biochem 38:29–38

    Article  Google Scholar 

  17. Nakajima N, Kuwayama H, Ito Y et al (1997) Helicobacter pylori, neutrophils, interleukins, and gastric epithelial proliferation. J Clin Gastroenterol 25:S198–S202

    Article  PubMed  Google Scholar 

  18. Jackson JR, Seed MP, Kircher CH et al (1997) The codependence of angiogenesis and chronic inflammation. FASEB J 11:457–465

    CAS  PubMed  Google Scholar 

  19. Dubé C, Rostom A, Lewin G et al (2007) The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. preventive services task force. Ann Intern Med 146:365–375

    PubMed  Google Scholar 

  20. Orlando RC (2002) Mechanisms of epithelial injury and inflammation in gastrointestinal diseases. Rev Gastroenterol Disord 2:S2–S8

    PubMed  Google Scholar 

  21. Hugot JP, Chamaillard M, Zouali H et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603

    Article  CAS  PubMed  Google Scholar 

  22. Ogura Y, Bonen DK, Inohara N et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606

    Article  CAS  PubMed  Google Scholar 

  23. Lesage S, Zouali H, Cézard JP et al (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845–857

    Article  CAS  PubMed  Google Scholar 

  24. Hampe J, Cuthbert A, Croucher PJ et al (2001) Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet 357:1925–1928

    Article  CAS  PubMed  Google Scholar 

  25. Heliö T, Halme L, Lappalainen M et al (2003) CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn’s disease. Gut 52:558–562

    Article  PubMed  Google Scholar 

  26. Kurzawski G, Suchy J, Kładny J et al (2004) The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 64:1604–1606

    Article  CAS  PubMed  Google Scholar 

  27. Papaconstantinou I, Theodoropoulos G, Gazouli M et al (2005) Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer 114:433–435

    Article  CAS  PubMed  Google Scholar 

  28. Alhopuro P, Ahvenainen T, Mecklin JP et al (2004) NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res 64:7245–7247

    Article  CAS  PubMed  Google Scholar 

  29. Tuupanen S, Alhopuro P, Mecklin JP et al (2007) No evidence for association of NOD2 R702W and G908R with colorectal cancer. Int J Cancer 121:76–79

    Article  CAS  PubMed  Google Scholar 

  30. Roberts RL, Gearry RB, Allington MD et al (2006) Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Res 66:2532–2535

    Article  CAS  PubMed  Google Scholar 

  31. Lakatos PL, Hitre E, Szalay F et al (2007) Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer 7:54

    Article  PubMed  Google Scholar 

  32. Möckelmann N, von Schönfels W, Buch S et al (2009) Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer. BMC Gastroenterol 9:79

    Article  PubMed  Google Scholar 

  33. Arnott ID, Nimmo ER, Drummond HE et al (2004) NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn’s disease patients: evidence for genetic heterogeneity within Europe? Genes Immun 5:417–425

    Article  CAS  PubMed  Google Scholar 

  34. Croucher PJ, Mascheretti S, Hampe J et al (2003) Haplotype structure and association to Crohn’s disease of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 11:6–16

    Article  CAS  PubMed  Google Scholar 

  35. Gaya DR, Russell RK, Nimmo ER et al (2006) New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 367:1271–1284

    Article  CAS  PubMed  Google Scholar 

  36. Henckaerts L, Van Steen K, Verstreken I et al (2009) Genetic risk profiling and prediction of disease course in Crohn’s disease patients. Clin Gastroenterol Hepatol 7:972–980

    Article  CAS  PubMed  Google Scholar 

  37. Annese V, Lombardi G, Perri F et al (2005) Variants of CARD15 are associated with an aggressive clinical course of Crohn’s disease–an IG-IBD study. Am J Gastroenterol 100:84–92

    Article  CAS  PubMed  Google Scholar 

  38. Hampe J, Grebe J, Nikolaus S et al (2002) Association of NOD2 (CARD 15) genotype with clinical course of Crohn’s disease: a cohort study. Lancet 359:1661–1665

    Article  CAS  PubMed  Google Scholar 

  39. Abreu MT, Taylor KD, Lin YC et al (2002) Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn’s disease. Gastroenterology 123:679–688

    Article  CAS  PubMed  Google Scholar 

  40. Economou M, Trikalinos TA, Loizou KT et al (2004) Differential effects of NOD2 variants on Crohn’s disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99:2393–2404

    Article  CAS  PubMed  Google Scholar 

  41. Radford-Smith G, Pandeya N (2006) Associations between NOD2/CARD15 genotype and phenotype in Crohn’s disease—are we there yet? World J Gastroenterol 12:7097–7103

    PubMed  Google Scholar 

  42. Allen JI (1995) Molecular biology of colon polyps and colon cancer. Semin Surg Oncol 11:399–405

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Coimbra University Hospital, Avenida Bissaya Barreto, 3000-076, Coimbra, Portugal

    Paulo Freire, Francisco Portela, Pedro Figueiredo, Manuela Ferreira, Pedro Amaro, Paulo Andrade, Hermano Gouveia & Carlos Sofia

  2. Department of Gastroenterology, Coimbra University Medical Faculty, Avenida Bissaya Barreto, 3000, Coimbra, Portugal

    Maria M. Donato, Pedro Figueiredo & Carlos Sofia

  3. Department of Oncology, Coimbra University Hospital, Avenida Bissaya Barreto, 3000, Coimbra, Portugal

    Anabela Sá

Authors
  1. Paulo Freire
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francisco Portela
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria M. Donato
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pedro Figueiredo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Manuela Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Pedro Amaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anabela Sá
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Paulo Andrade
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hermano Gouveia
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Carlos Sofia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paulo Freire.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Freire, P., Portela, F., Donato, M.M. et al. CARD15 mutations and colorectal cancer in a South European country. Int J Colorectal Dis 25, 1211–1219 (2010). https://doi.org/10.1007/s00384-010-1028-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-010-1028-0

Keywords

Search

Navigation